Cargando…
Successful treatment of cholesterol crystal embolism with anti-proprotein convertase subtilisin/kexin type 9 (PCSK9) antibody: a case report
BACKGROUND: We report a unique case of renal cholesterol crystal embolism (CCE) induced by carotid artery stenting that was successfully treated with evolocumab, a fully human monoclonal antibody against proprotein convertase subtilisin kexin type 9 (PCSK9). CASE PRESENTATION: A 77-year-old man with...
Autores principales: | Morino, Junki, Hirai, Keiji, Kaneko, Shohei, Minato, Saori, Yanai, Katsunori, Mutsuyoshi, Yuko, Ishii, Hiroki, Matsuyama, Momoko, Kitano, Taisuke, Shindo, Mitsutoshi, Aomatsu, Akinori, Miyazawa, Haruhisa, Ito, Kiyonori, Ueda, Yuichiro, Ookawara, Susumu, Morishita, Yoshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034108/ https://www.ncbi.nlm.nih.gov/pubmed/32046605 http://dx.doi.org/10.1080/0886022X.2020.1726383 |
Ejemplares similares
-
Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)
por: Schulz, Rainer, et al.
Publicado: (2015) -
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
por: O’Connell, Emma M., et al.
Publicado: (2020) -
Hepatocellular carcinoma-associated hypercholesterolemia: involvement of proprotein-convertase-subtilisin-kexin type-9 (PCSK9)
por: Athavale, Dipti, et al.
Publicado: (2018) -
Plasma Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) in the Acute Respiratory Distress Syndrome
por: Metkus, Thomas S., et al.
Publicado: (2022) -
Proprotein convertase subtilisin/kexin type 9 (PCSK9) Deficiency is Protective Against Venous Thrombosis in Mice
por: Wang, Hui, et al.
Publicado: (2017)